Core to Evidence-Based Health Policy
cost-effectiveness evaluation for future healthcare
C2H is the only public research organization
for official cost-effectiveness evaluation process
in Japan
C2H (Center for Outcomes Research and Economic Evaluation for Health) is an organization of National Institute of Public Health; it conducts academic analysis of cost-effectiveness evaluation from the scientific viewpoint. This website will dispatch information about cost-effectiveness evaluation in Japan. We are happy if this website contributes to evidence-based health policy (EBHP).
Tools for cost-effectiveness evaluation
Latest news
-
news
New C2H Report: Awiqli (Insulin Icodec)
Report of the cost-effectiveness evaluation on Awiqli (Insulin Icodec) was released.
-
news
New C2H Report: Nirmatrelvir/Ritonavir (Paxlovid)
Report of the cost-effectiveness evaluation on Nirmatrelvir/Ritonavir (Paxlovid) was released.
-
news
New C2H Report: Sacituzumab Govitecan (TRODELVY)
Report of the cost-effectiveness evaluation on Sacituzumab Govitecan (TRODELVY) was released.